Mass Production of Beneficial Organisms 2014
DOI: 10.1016/b978-0-12-391453-8.00015-7
|View full text |Cite
|
Sign up to set email alerts
|

Mass Production of Entomopathogens in Less Industrialized Countries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
13
0
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 61 publications
0
13
0
2
Order By: Relevance
“…2009; Grzywacz et al, 2014a) but the relatively high cost of producing BV in living insects 366 compared to their chemical insecticide counterparts remains a constraint as farm prices are 367 difficult to reduce below $20 per ha and scaling up in vivo BV production with its demands for 368 high quality disease-free insects is also a challenge (Reid et al, 2014). The use of automation 369 and mechanization in inoculation, rearing, and harvesting has facilitated mass production and 370 made BV a viable commercial option for the current range and usage scale.…”
Section: Research Issues That Constrain Expansion Of the Use Insect Vmentioning
confidence: 99%
“…2009; Grzywacz et al, 2014a) but the relatively high cost of producing BV in living insects 366 compared to their chemical insecticide counterparts remains a constraint as farm prices are 367 difficult to reduce below $20 per ha and scaling up in vivo BV production with its demands for 368 high quality disease-free insects is also a challenge (Reid et al, 2014). The use of automation 369 and mechanization in inoculation, rearing, and harvesting has facilitated mass production and 370 made BV a viable commercial option for the current range and usage scale.…”
Section: Research Issues That Constrain Expansion Of the Use Insect Vmentioning
confidence: 99%
“…También, es importante validar los pará-metros de procesos optimizados a escala de laboratorio en una escala mayor (Monzón, 2001;Ravensberg, 2011), con el fin de realizar los ajustes necesarios al proceso que garanticen mantener el rendimiento del proceso. Otros factores importantes para tener en cuenta durante el desarrollo del proceso de producción son: el tipo de mercado al que está dirigido el producto, el tamaño del mercado, el capital disponible para invertir, y la cantidad de recurso humano disponible (Grzywacz et al, 2014). Los métodos de producción desarrollados incluyen desde la multiplicación artesanal, la producción semi-industrial a mediana escala, hasta la producción industrial a gran escala que se realiza en empresas más grandes o compañías, para la cual se requiere de reactivos y equipos más especializados.…”
Section: Introductionunclassified
“…Los métodos de producción desarrollados incluyen desde la multiplicación artesanal, la producción semi-industrial a mediana escala, hasta la producción industrial a gran escala que se realiza en empresas más grandes o compañías, para la cual se requiere de reactivos y equipos más especializados. En Latinoamérica mayormente se utiliza el mecanismo de baja tecnología, con alta demanda de mano de obra, y en algunos casos realizado por los mismos productores (Grzywacz et al, 2014;Monzón, 2001).…”
Section: Introductionunclassified
“…To promote the expansion of the use of EPNs as biological control agents, current research focuses on the development of low-cost formulations with: greater storage stability at room temperature, increased resistance during the transportation to the application site, where it dissolves for application in aqueous medium or it is deposited directly on moist soil (Burges, 1998;Grewal, 2000;Grzywacz et al, 2014), effective control of target insect pest and greater persistence in the field (Grewal, 2002;Shapiro-Ilan et al, 2012). The EPN formulation in gelling materials partially satisfies these requirements since it has been designed to provide a hydrophilic environment that prevents or delays the desiccation to increase its survival, especially on foliar surfaces (Navon et al, 2002).…”
mentioning
confidence: 99%
“…The success of EPN infection depends on the storage stability of the formulated product, which is also important for marketing; therefore, there is still scope for increasing that parameter (Navon et al, 2002;Sharma et al, 2011), but keeping it cheap and attending to its ease of use (Grzywacz et al, 2014). Some suggested strategies to improve the alginate formulation are: harden the surface to retain EPNs over an extended period of time (Hiltpold et al, 2012), slow down EPN metabolism before the formulation, probably forcing them into a partial anhidrobiosis through slow desiccation in glycerol, but maintaining the EPN infectiousness, and enhance it once the state dormancy breaks (Hiltpold, 2015;Kary et al, 2016).…”
mentioning
confidence: 99%